Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 75

1.

Clinical trial issues in weight-loss therapy.

Patel MR, Donahue M, Wilson PW, Califf RM.

Am Heart J. 2006 Mar;151(3):633-42. Review.

PMID:
16504625
2.

Systematic review of the long-term effects and economic consequences of treatments for obesity and implications for health improvement.

Avenell A, Broom J, Brown TJ, Poobalan A, Aucott L, Stearns SC, Smith WC, Jung RT, Campbell MK, Grant AM.

Health Technol Assess. 2004 May;8(21):iii-iv, 1-182. Review.

3.

Medical strategies for weight loss in the overweight and obese patient.

Di Caro S, Hamad GG, Fernstrom MH, Schauer PR, Bonanomi G.

Minerva Gastroenterol Dietol. 2006 Dec;52(4):415-30. Review.

PMID:
17108871
4.

Adherence to weight loss medications; post-marketing study from HMO pharmacy data of one million individuals.

Hemo B, Endevelt R, Porath A, Stampfer MJ, Shai I.

Diabetes Res Clin Pract. 2011 Nov;94(2):269-75. doi: 10.1016/j.diabres.2011.08.021. Epub 2011 Sep 9.

PMID:
21907442
5.

Treatment of binge eating disorder.

Wilson GT.

Psychiatr Clin North Am. 2011 Dec;34(4):773-83. doi: 10.1016/j.psc.2011.08.011. Epub 2011 Oct 5.

PMID:
22098803
6.

Combining behavioral and pharmacological treatments for obesity.

Phelan S, Wadden TA.

Obes Res. 2002 Jun;10(6):560-74. Review.

7.

[What effect does losing weight have on hypertension?].

Engeli S.

MMW Fortschr Med. 2003 Jul 10;145(27-28):44. German. No abstract available.

PMID:
14587188
8.

Is there a path for approval of an antiobesity drug: what did the Sibutramine Cardiovascular Outcomes Trial find?

Downey M, Still C, Sharma AM.

Curr Opin Endocrinol Diabetes Obes. 2011 Oct;18(5):321-7. doi: 10.1097/MED.0b013e32834a8726. Review.

PMID:
21878755
9.

Obesity and pharmacologic therapy.

Thearle M, Aronne LJ.

Endocrinol Metab Clin North Am. 2003 Dec;32(4):1005-24. Review.

PMID:
14711072
10.

New antiobesity agents in type 2 diabetes: overview of clinical trials with sibutramine and orlistat.

Scheen AJ, Ernest P.

Diabetes Metab. 2002 Dec;28(6 Pt 1):437-45. Review.

11.

Weight loss in obese African American and Caucasian adolescents: secondary analysis of a randomized clinical trial of behavioral therapy plus sibutramine.

Budd GM, Hayman LL, Crump E, Pollydore C, Hawley KD, Cronquist JL, Berkowitz RI.

J Cardiovasc Nurs. 2007 Jul-Aug;22(4):288-96.

PMID:
17589281
12.

Medical management of obesity: a clinical imperative?

Haynes WG.

Curr Diab Rep. 2003 Feb;3(1):1-3. Review. No abstract available.

PMID:
12643140
13.

[New drugs for the treatment of obesity].

Mustajoki P.

Duodecim. 1999;115(20):2191, 2193-4. Finnish. No abstract available.

PMID:
11973921
14.

Treatment modalities of obesity: what fits whom?

Hainer V, Toplak H, Mitrakou A.

Diabetes Care. 2008 Feb;31 Suppl 2:S269-77. doi: 10.2337/dc08-s265. Review.

PMID:
18227496
15.

Weight management and current options in pharmacotherapy: orlistat and sibutramine.

Leung WY, Thomas GN, Chan JC, Tomlinson B.

Clin Ther. 2003 Jan;25(1):58-80. Review.

PMID:
12637112
16.

Obesity.

Fabricatore AN, Wadden TA.

Annu Rev Clin Psychol. 2006;2:357-77. Review.

PMID:
17716074
17.

How to help your patients lose weight: current therapy for obesity.

Weiss D.

Cleve Clin J Med. 2000 Oct;67(10):739, 743-6, 749-54. Review.

PMID:
11060960
18.
19.

Obesity and cardiovascular disease: pathogenic mechanisms and potential benefits of weight reduction.

Douketis JD, Sharma AM.

Semin Vasc Med. 2005 Feb;5(1):25-33. Review.

PMID:
15968577
20.

Pharmacologic agents for the treatment of obesity.

Mathys M.

Clin Geriatr Med. 2005 Nov;21(4):735-46, vii. Review.

PMID:
16182086

Supplemental Content

Support Center